SELLAS Life Sciences Group share price logo

SELLAS Life Sciences Group

NASDAQ: SLS

Mid Cap

$9.99

-1.35

(-11.90%)

as on

SELLAS Life Sciences Group Stock Performance

as on October 17, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $9.75
    $11.24
    downward going graph

    2.40%

    Downside

    12.51%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.39
    $15.88
    downward going graph

    86.09%

    Downside

    58.92%

    Upside

    downward going graph

SELLAS Life Sciences Group share price movements today

Previous Close
$11.34
Open
$11.24
Volume
17.5M
Market Cap
$2.4B
Day's Low - High
$9.75 - $11.24
52 Week Low - High
$1.39 - $15.88

SELLAS Life Sciences Group Historical Returns

1 Month Return
-2.74 %
3 Month Return
-3.49 %
1 Year Return
+ 425 %
3 Year Return
+ 792.91 %
5 Year Return
+ 28.43 %

SELLAS Life Sciences Group Stock Fundamentals & Key Indicators

Check SELLAS Life Sciences Group market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4B

EPS (TTM)

-0.2113

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-53.67

Industry PE ratio

-11.30

PEG Ratio

-1.16

EBITDA

-25.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-35.91%

SELLAS Life Sciences Group vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of SELLAS Life Sciences Group with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$2.4B28.43%-53.670.00%0.00%
Neutral$90.3B-27.05%-29.64-12.57%0.00%
StrongBuy$126.4B179.89%28.7886.04%0.00%
Buy$77.5B43.94%19.0184.86%0.48%

Stock Returns calculator for SELLAS Life Sciences Group Stock including INR - Dollar returns

The SELLAS Life Sciences Group stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

SELLAS Life Sciences Group investment value today

Current value as on today

₹4,99,133

Returns

₹3,99,133

(+399.13%)

Returns from SELLAS Life Sciences Group Stock

₹3,62,500 (+362.5%)

Dollar Impact

₹36,633 (+36.63%)

Analyst Recommendation on SELLAS Life Sciences Group Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for SELLAS Life Sciences Group. Average target price of $32.5

SELLAS Life Sciences Group Share Price Target

Get share price movements and forecasts by analysts on SELLAS Life Sciences Group.

What analysts predicted

69.26%UPSIDE

Target Price

$32.5

Current Price

$9.99

Analyzed by

7 Analysts

Target

$32.50

SELLAS Life Sciences Group target price $32.5, a slight upside of 69.26% compared to current price of $9.99. According to 7 analysts rating.

Indian Investors' Interest in SELLAS Life Sciences Group Stock

Investment in SELLAS Life Sciences Group Shares on INDmoney has dropped by -10.92% in the last 30 days, indicating reduced investment activity.

Time period: to

Change:-10.92% versus previous 30 day period

Search interest for SELLAS Life Sciences Group Stock has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-58% versus previous 30 day period

SELLAS Life Sciences Group Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-9
-7
-7
-6
-6
-6
-7
-8
-9
-10
EBITDA
-9
-7
-7
-6
-5
-6
0
-7
-8
-9
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
7
-
-
-
Income Before Tax
-9
-7
-7
-6
-5
-6
-6
-7
-8
-9
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-9
-7
-7
-6
-5
-6
-6
-7
-8
-9
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

SELLAS Life Sciences Group Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
1
7
1
-
-
-
Gross Profit
-
-
-
1
7
0
-
-
-
Operating Income
-15
-31
-20
-16
-25
-41
-37
-31
-28
EBITDA
-22
-6
-
-16
-18
-31
0
0
-26
Interest Expense
0
0
0
-
-
-
-
-
-
Depreciation
0
22
17
0
1
0
37
31
-
Income Before Tax
-23
-29
-19
-16
-20
-41
-37
-30
-26
Income Tax Expense
0
-1
0
0
0
-
-
-
-
Net Income
-23
-27
-19
-16
-20
-41
-37
-30
-26
Net Profit Margin
0.00%
0.00%
0.00%
100.00%
97.37%
90.00%
0.00%
0.00%
0.00%

SELLAS Life Sciences Group Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-9
-7
-7
-6
-5
-6
-6
-7
-8
-9
Operating Cash Flow
-10
-9
-7
-7
-9
-7
-7
-4
-8
-7
Investing Cash Flow
-
-
-
-
-
-
-
-
-
-
Financing Cash Flow
26
0
19
0
23
4
26
32
44
38
Change in Cash
15
-9
11
-7
14
-3
19
27
35
31

SELLAS Life Sciences Group Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-23
-27
-19
-16
-20
-41
-37
-30
-26
Operating Cash Flow
-10
-30
-17
-10
-26
-23
-31
-35
-28
Investing Cash Flow
1
-
-
-
-
-4
-5
-
-
Financing Cash Flow
5
23
19
38
12
24
22
46
86
Change in Cash
-3
-7
1
28
-13
-4
-14
11
57

Global Institutional Holdings in SELLAS Life Sciences Group

Check out the Institutions with significant holdings in SELLAS Life Sciences Group.

Funds
Holdings
Vanguard
5.12%
iShares
4.25%
VANGUARD INDEX FUNDS
3.40%
SPDR
3.30%
Bruce Winson
2.23%

SELLAS Life Sciences Group News & Key Events

    Insights on SELLAS Life Sciences Group

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 year, SLS stock has moved up by 425.0%

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, SLS has outperformed top 5 stocks with highest market-cap in its industry

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 771.4% return, outperforming this stock by 346.4%

    About SELLAS Life Sciences Group

    SELLAS Life Sciences Group, Inc., a late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States. The company's lead product candidate is galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1, antigen; and SLS009 (tambiciclib), a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors; GenFleet Therapeutics (Shanghai), Inc. for the development and commercialization of GFH009; and Memorial Sloan Kettering Cancer Center for developing and commercializing MSK's WT1 peptide vaccine technology. SELLAS Life Sciences Group, Inc. is headquartered in New York, New York.
    OrganisationSELLAS Life Sciences Group
    Headquarters7 Times Square, New York, NY, 10036, US
    IndustryBiotechnology
    CEOAngelos Stergiou

    Key Management of SELLAS Life Sciences Group

    Name

    Title

    Dr. Angelos M. Stergiou M.D., ScD h.c.

    Founder, President, CEO & Director

    Mr. John Thomas Burns CPA

    Senior VP & CFO

    Dr. Dragan Cicic M.D., MBA

    Senior VP & Chief Development Officer

    Ms. Stacy E. Yeung

    VP, General Counsel & Corporate Secretary

    Mr. Andrew Elnatan

    Senior VP of Regulatory Affairs, CMC & Quality

    FAQs

    What is SELLAS Life Sciences Group share price today?

    SELLAS Life Sciences Group share price today is $9.99 as on at the close of the market. SELLAS Life Sciences Group share today touched a day high of $11.24 and a low of $9.75.

    What is the 52 week high and 52 week low for SELLAS Life Sciences Group share?

    SELLAS Life Sciences Group share touched a 52 week high of $15.88 on and a 52 week low of $1.39 on . SELLAS Life Sciences Group stock price today i.e. is closed at $9.99,which is 37.08% down from its 52 week high and 618.71% up from its 52 week low.

    What is SELLAS Life Sciences Group's market capitalisation today?

    SELLAS Life Sciences Group market capitalisation is $0.00T as on .

    How to invest in SELLAS Life Sciences Group Stock (SLS) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for SELLAS Life Sciences Group on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy SELLAS Life Sciences Group Stock (SLS) from India?

    Indian investors can start investing in SELLAS Life Sciences Group (SLS) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹949.60 in SELLAS Life Sciences Group stock (as per the Rupee-Dollar exchange rate as on ). Based on SELLAS Life Sciences Group share’s latest price of $9.99 as on October 17, 2026 at 1:29 am IST, you will get 1.0010 shares of SELLAS Life Sciences Group. Learn more about fractional shares .

    What are the returns that SELLAS Life Sciences Group has given to Indian investors in the last 5 years?

    SELLAS Life Sciences Group stock has given 28.43% share price returns and 26.69% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?